Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons.
Fasciani I, Petragnano F, Bono F, Aloisi G, Mutti V, Pardini C, Carli M, Scarselli M, Vaglini F, Angelucci A, Fiorentini C, Lozzi L, Missale C, Maggio R, Rossi M. Fasciani I, et al. Among authors: vaglini f. Neuroscience. 2024 Apr 19;544:104-116. doi: 10.1016/j.neuroscience.2024.01.009. Epub 2024 Jan 18. Neuroscience. 2024. PMID: 38244669 Free article.
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics.
Carli M, Weiss F, Grenno G, Ponzini S, Kolachalam S, Vaglini F, Viaggi C, Pardini C, Tidona S, Longoni B, Maggio R, Scarselli M. Carli M, et al. Among authors: vaglini f. Curr Neuropharmacol. 2023;21(4):935-950. doi: 10.2174/1570159X21666230224102318. Curr Neuropharmacol. 2023. PMID: 36825703 Free PMC article.
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib.
Orlandi P, Banchi M, Vaglini F, Carli M, Aringhieri S, Bandini A, Pardini C, Viaggi C, Lai M, Alì G, Ottani A, Vandini E, Guidi P, Bernardeschi M, La Rocca V, Francia G, Fontanini G, Pistello M, Frenzilli G, Giuliani D, Scarselli M, Bocci G. Orlandi P, et al. Among authors: vaglini f. Biochem Pharmacol. 2024 Jan;219:115952. doi: 10.1016/j.bcp.2023.115952. Epub 2023 Nov 29. Biochem Pharmacol. 2024. PMID: 38036189 Free article.
Connexin 26 Expression in Mammalian Cardiomyocytes.
Moscato S, Cabiati M, Bianchi F, Vaglini F, Morales MA, Burchielli S, Botta L, Sabbatini ARM, Falleni A, Del Ry S, Mattii L. Moscato S, et al. Among authors: vaglini f. Sci Rep. 2018 Sep 18;8(1):13975. doi: 10.1038/s41598-018-32405-2. Sci Rep. 2018. PMID: 30228305 Free PMC article.
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: Synthesis and pharmacological effects.
Robello M, Salerno S, Barresi E, Orlandi P, Vaglini F, Banchi M, Simorini F, Baglini E, Poggetti V, Taliani S, Da Settimo F, Bocci G. Robello M, et al. Among authors: vaglini f. Arch Pharm (Weinheim). 2022 Nov;355(11):e2200295. doi: 10.1002/ardp.202200295. Epub 2022 Jul 29. Arch Pharm (Weinheim). 2022. PMID: 35904260
Parkinson's disease and light: The bright and the Dark sides.
Maggio R, Vaglini F, Rossi M, Fasciani I, Pietrantoni I, Marampon F, Corsini GU, Scarselli M, Millan MJ. Maggio R, et al. Among authors: vaglini f. Brain Res Bull. 2019 Aug;150:290-296. doi: 10.1016/j.brainresbull.2019.06.013. Epub 2019 Jun 19. Brain Res Bull. 2019. PMID: 31226407 Review.
97 results